Dr. Hui Zhu 朱慧
Chief Physician
Department of Thoracic Radiation Oncology I, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Comprehensive treatment of chest tumors, including lung cancer, thymoma, esophageal cancer, and breast cancer. Specializes in radiotherapy for lung cancer and thymoma, and prophylactic cranial irradiation for brain metastases in small cell lung cancer.
Dr. Zhu holds a PhD in radiotherapy from Peking Union Medical College and the Cancer Hospital of the Chinese Academy of Medical Sciences, following undergraduate and master’s degrees from Shandong University. Training included one year at Stanford University Cancer Center focusing on SBRT for early-stage lung cancer, under the mentorship of Academician Yu Jinming and Professor Wang Luhua.
Professional roles
- Chair, Small Cell Lung Cancer Branch, Shandong Anti-Cancer Association
- Standing Committee Member, Radiotherapy Committee, Shandong Anti-Cancer Association
- Member, Radiotherapy Committee, China Anti-Cancer Association
- Standing Committee Member, Radiotherapy Branch, China Geriatric Oncology Society
Name order: in Chinese the family name comes first (Zhu Hui). Papers usually list the name as Hui Zhu or Zhu H.
Selected publications
166 papers on PubMed matched by name and affiliation; 53 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Cancer, 2026 (senior author): Reassessing the Incidence and Risk Factors of Radiation Pneumonitis in Treatment-Naive EGFR-Mutant NSCLC With Concurrent Third-Generation EGFR-TKI and Thoracic Radiotherapy. PubMed 42363769
- Front Immunol, 2026 (senior author): Intratumoral microbiota: bidirectional modulation of tumor radiosensitivity. PubMed 42889528
- Biochim Biophys Acta Rev Cancer, 2026 (senior author): Radiotherapy-induced PD-L1 conversion in esophageal squamous cell carcinoma: From multidimensional mechanisms to clinical rescue strategies. PubMed 42778075
- J Clin Oncol, 2026 (senior author): Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment. PubMed 42133905
- Oncol Lett, 2026 (senior author): Weekly cisplatin and nab-paclitaxel neoadjuvant chemoradiotherapy increases pathological complete response in locally advanced esophageal squamous cell carcinoma: A real-world study. PubMed 42180618
- Lung Cancer, 2026 (senior author): Treatment patterns of elderly patients with limited-stage small-cell lung cancer in real-world data: A multicentre retrospective analysis. PubMed 42134158
- Ther Adv Med Oncol, 2026 (senior author): Consolidation thoracic radiotherapy after chemoimmunotherapy provides survival benefit in elderly patients with extensive-stage small-cell lung cancer: a multicenter study. PubMed 42125428
- Future Oncol, 2026 (senior author): Concurrent immunotherapy is associated with increased radiation necrosis risk in lung cancer patients with brain metastases treated with stereotactic radiosurgery. PubMed 41858132
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion